We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.68B
AUM Growth
-$145M
Cap. Flow
-$113M
Cap. Flow %
-2.41%
Top 10 Hldgs %
14.09%
Holding
1,671
New
224
Increased
657
Reduced
447
Closed
328

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$29M
2
NU icon
Nu Holdings
NU
+$25.8M
3
PG icon
Procter & Gamble
PG
+$23.5M
4
NKE icon
Nike
NKE
+$23.1M
5
GRAB icon
Grab
GRAB
+$22.3M

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$44.7M
2
NTES icon
NetEase
NTES
+$40.5M
3
AMD icon
Advanced Micro Devices
AMD
+$37.8M
4
MELI icon
Mercado Libre
MELI
+$33.9M
5
PDD icon
Pinduoduo
PDD
+$33.8M

Sector Composition

Rank Sector Weight
1 Technology 30.82%
2 Consumer Discretionary 19.78%
3 Communication Services 10.14%
4 Financials 6.66%
5 Industrials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVTX icon
1551
Travere Therapeutics
TVTX
$5.78B
-1,390
Closed -$33K
TWST icon
1552
Twist Bioscience
TWST
$7.25B
-1,130
Closed -$120K
TXMD icon
1553
TherapeuticsMD
TXMD
$24M
-194
Closed -$7K
UBX
1554
DELISTED
Unity Biotechnology
UBX
-126
Closed -$3K
UPBD icon
1555
Upbound Group
UPBD
$1.16B
-23,640
Closed -$1.33M
URGN icon
1556
UroGen Pharma
URGN
$2.29B
-510
Closed -$8K
VCYT icon
1557
Veracyte
VCYT
$3.8B
-1,615
Closed -$75K
VIGI icon
1558
Vanguard International Dividend Appreciation ETF
VIGI
$9.3B
-378
Closed -$32K
VIR icon
1559
Vir Biotechnology
VIR
$1.49B
-2,990
Closed -$130K
VMEO
1560
DELISTED
Vimeo
VMEO
-466
Closed -$13K
VNDA icon
1561
Vanda Pharmaceuticals
VNDA
$302M
-1,275
Closed -$21K
VO icon
1562
Vanguard Morningstar Mid-Cap ETF
VO
$109B
-320
Closed -$18K
VSTM icon
1563
Verastem
VSTM
$610M
-344
Closed -$12K
VIVO
1564
VivoPower PLC
VIVO
$124M
-222
Closed -$12K
VYGR icon
1565
Voyager Therapeutics
VYGR
$201M
-870
Closed -$2K
VYMI icon
1566
Vanguard International High Dividend Yield ETF
VYMI
$20.9B
-512
Closed -$33K
YARW
1567
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
-1
Closed -$1K
WVE icon
1568
Wave Life Sciences
WVE
$1.2B
-1,165
Closed -$5K
XBIT icon
1569
XBiotech
XBIT
$69.2M
-695
Closed -$9K
XENE icon
1570
Xenon Pharmaceuticals
XENE
$6.12B
-940
Closed -$14K
XNCR icon
1571
Xencor
XNCR
$1.55B
-1,335
Closed -$43K
YJ
1572
Yunji
YJ
$16.7M
-1,370
Closed -$39K
YMAB
1573
DELISTED
Y-mAbs Therapeutics
YMAB
-995
Closed -$28K
YQ
1574
17 Education & Technology Group
YQ
$23.2M
-6,510
Closed -$116K
ZG icon
1575
Zillow
ZG
$7.63B
-38
Closed -$3K

Similar funds

Penserra Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Penserra Capital Management held 1,671 positions worth $4.68B, down 3% from $4.82B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Penserra Capital Management's Q4 2021 filing shows 224 new, 657 increased, 447 reduced and 328 closed positions. Its largest new stake was Marathon Petroleum: 451,379 shares worth $28.9M. The largest sale was JD.com, an estimated $44.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q4 2021 buy was Marathon Petroleum: 451,379 shares worth $28.9M.
  • Penserra Capital Management added most to Procter & Gamble in Q4 2021, an estimated $23.5M increase.
  • Penserra Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $44.7M.
  • Penserra Capital Management fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $32.7M.
  • Penserra Capital Management's ten largest holdings make up 14% of its $4.68B portfolio in Q4 2021.
  • Penserra Capital Management opened 224 new positions and closed 328 in Q4 2021.
  • Penserra Capital Management's portfolio value fell 3% quarter-over-quarter to $4.68B.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.